Frequency and differentiation capacity of circulating LTC-IC mobilized by G-CSF or GM-CSF following chemotherapy - A comparison with steady-state bone marrow and peripheral blood

Experimental Hematology

Volumn 30, Issue 1, 2002, Pages 74-81

  Benboubker, Lotfi ^a   Binet, Christian ^a   Cartron, Guillaume ^a   Bernard, Marie Christine ^a   Clement, Nathalie ^a   Domenech, Jorge ^a   Degenne, Michel ^a   Delain, Michel ^a   Colombat, Philippe ^a   Desbois, I ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD CELL; BONE MARROW; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL; STEM CELL MOBILIZATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELLS; BONE MARROW CELLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED;

EID: 18244401976     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00762-7     Document Type: Article

References (35)

1. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
2. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy (see comments)
3. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood
4. 2) and granulocyte colony-stimulating factor in patients with multiple myeloma
5. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma
6. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor; an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma
7. + bone marrow cells
8. - hematopoietic stem cells
9. + cells
10. + cells with a different antigenic profile compared with use during steady-state hematopoiesis
11. Conditions controlling the proliferation of haemopoietic stem cells in vitro
12. Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide
13. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro
14. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
15. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow 'switch' cultures
16. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse
17. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population
18. - cells in cord blood and bone marrow
19. Quantitation, mobilization, and clinical use of long-term culture-initiating cells in blood cell autografts
20. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
21. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF; potential role in allogeneic marrow transplantation
22. G-CSF vs GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers; comparison of efficacy and tolerability
23. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells
24. Comparative effects of three cytokine regimens after high-dose cyclophosphamide; granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF
25. + cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF
26. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow
27. - progenitor cells in long-term cultures and semisolid assays
28. The evaluation of limiting dilution assays
29. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy
30. Erythroid burst-promoting activity of purified recombinant human GM-CSF and interleukin-3; studies with anti-GM-CSF and anti-IL-3 sera and studies in serum-free cultures
31. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants
32. + cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens
33. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor
34. + cells expressing different levels of HLA-DR, CD33, CD38, and c-kit antigens
35. Stem cell factor modulates avidity of α4β1 and α5 β1 integrins expressed on hematopoietic cell lines